BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10657685)

  • 1. Effect of cisapride on acid gastro-oesophageal reflux during treatment with caffeine.
    Kentrup H; Baisch HJ; Kusenbach G; Heimann G; Skopnik H
    Biol Neonate; 2000 Feb; 77(2):92-5. PubMed ID: 10657685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride decreases gastroesophageal reflux in preterm infants.
    Ariagno RL; Kikkert MA; Mirmiran M; Conrad C; Baldwin RB
    Pediatrics; 2001 Apr; 107(4):E58. PubMed ID: 11335779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisapride treatment for gastro-oesophageal reflux in children.
    Augood C; Gilbert R; Logan S; MacLennan S
    Cochrane Database Syst Rev; 2002; (3):CD002300. PubMed ID: 12137654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisapride treatment for gastro-oesophageal reflux in children.
    Maclennan S; Augood C; Cash-Gibson L; Logan S; Gilbert RE
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002300. PubMed ID: 20393933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisapride treatment for gastro-oesophageal reflux in children.
    Augood C; MacLennan S; Gilbert R; Logan S
    Cochrane Database Syst Rev; 2003; (4):CD002300. PubMed ID: 14583950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride treatment for gastro-oesophageal reflux in children.
    Augood C; MacLennan S; Gilbert R; Logan S
    Cochrane Database Syst Rev; 2000; (3):CD002300. PubMed ID: 10908549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of a 40-mg extended-release formulation of cisapride in the treatment of patients with gastro-oesophageal reflux.
    Katschinski M; Schirra J; Arnold R
    Aliment Pharmacol Ther; 2000 Jan; 14(1):113-22. PubMed ID: 10632654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [QTc interval in newborns with gastroesophageal reflux treated with cisapride and ranitidine].
    Lista G; Maestri L; Meroni M; Massari D; Colli A; Porcelli F; Menchini M; Introvini P; Compagnoni G
    Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():633-6. PubMed ID: 11424819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cisapride treatment for children with gastro-esophageal reflux].
    Kneepkens CM; Hoekstra JH; Vandenplas Y
    Ned Tijdschr Geneeskd; 1999 Oct; 143(42):2091-4. PubMed ID: 10560558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of cisapride in preterm infants.
    Vandenplas Y
    Arch Dis Child Fetal Neonatal Ed; 2000 Jul; 83(1):F75. PubMed ID: 10917722
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
    Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
    Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
    Vandenplas Y; Belli DC; Benatar A; Cadranel S; Cucchiara S; Dupont C; Gottrand F; Hassall E; Heymans HS; Kearns G; Kneepkens CM; Koletzko S; Milla P; Polanco I; Staiano AM
    J Pediatr Gastroenterol Nutr; 1999 May; 28(5):518-28. PubMed ID: 10328131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
    Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
    Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lengthening of the QT-interval in a newborn treated with cisapride].
    Heeringa M; Pulles-Heintzberger CF; van Puijenbroek EP; Verduijn MM
    Ned Tijdschr Geneeskd; 1999 Oct; 143(42):2108-11. PubMed ID: 10560562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
    Gardner JD; Rodriguez-Stanley S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1819-29. PubMed ID: 12269977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease.
    Ruth M; Finizia C; Cange L; Lundell L
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1115-21. PubMed ID: 14501621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cisapride on gastric emptying in premature infants with feed intolerance.
    Barnett CP; Omari T; Davidson GP; Goodchild L; Lontis R; Dent J; Haslam RR
    J Paediatr Child Health; 2001 Dec; 37(6):559-63. PubMed ID: 11903835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease.
    Finizia C; Lundell L; Cange L; Ruth M
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):9-14. PubMed ID: 11782569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Are prokinetic drugs still indicated for gastro-oesophageal reflux in children?].
    Dupont C; Benhamou PH
    Arch Pediatr; 2004 Jun; 11(6):671-3. PubMed ID: 15158877
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and tolerability of cisapride in children.
    Vandenplas Y; Benatar A; Cools F; Arana A; Hegar B; Hauser B
    Paediatr Drugs; 2001; 3(8):559-73. PubMed ID: 11577921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.